FDA Adverse Event Injury Summary report: N

ESSURE

MDR report key: 3820086 · Received May 14, 2014

Report

Report Number
2951250-2014-00153
Event Type
Injury
Date Received
May 14, 2014
Date of Event
April 7, 2014
Report Date
January 19, 2017
Manufacturer
BAYER PHARMA AG
Product Code
HHS
PMA / PMN Number
P020014
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
N

Narratives

Description of Event or Problem · 1

THIS IS A SPONTANEOUS CAE REPORT RECEIVED FROM A GYNECOLOGIST/OBSTETRICIAN IN (B)(6) ON (B)(6) 2014 WHICH REFERS TO A FEMALE PT OF UNSPECIFIED AGE WHO HAD AN ATTEMPT OF ESSURE (FALLOPIAN TUBE OCCLUSION INSERT) INSERTION AND IT WAS IMPOSSIBLE TO RELEASE THE DEVICE: BROKEN CATHETER AND IMPOSSIBLE WITHDRAWAL AND THE DELIVERY WAS NOT BILATERAL. NO INFO GIVEN ON PT'S HISTORY, PAST DRUGS, CONCURRENT CONDITIONS OR CONCOMITANT MEDICATION. ON (B)(6) 2014 THE PT HAD AN ATTEMPT OF ESSURE (FALLOPIAN TUBE OCCLUSION INSERT) INSERTION, LOT NUMBER 50750351. THE REPORTER STATED THAT, ALTHOUGH CONDITIONS OF THE PLACEMENT WERE EXCELLENT, DURING DEVICE PLACEMENT THE COILS DEVICE WAS NOT RELEASED AND IT WAS IMPOSSIBLE TO REMOVE THE CATHETER (BROKEN CATHETER AND IMPOSSIBLE WITHDRAWAL). THE DELIVERY WAS NOT BILATERAL AND A CELIOSCOPY TO REMOVE DEVICE WAS REQUIRED. THE DEVICE WAS KEPT IN THE HOSPITAL. THE CRITERION OF SERIOUSNESS WAS BY THE REPORTER AS A SERIOUS RISK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
288918 ESSURE INSERT, TUBAL OCCLUSION HHS BAYER PHARMA AG ESS305 50750351
288919 ESSURE INSERT, TUBAL OCCLUSION HHS BAYER PHARMA AG ESS305 50750351

Patients

Seq Age Sex Outcome Treatment
1 Female Other